The field of medicine has witnessed a remarkable transformation in recent years, thanks to the rapid advancements in genomic and molecular research. This evolution has given rise to personalized medicine, a revolutionary approach that tailors healthcare strategies to individual genetic profiles. The Wisconsin Biohealth Summit, scheduled for October 17th at the Overture Performing Arts Center, is set to explore the theme of “The Next Generation of Personalized Medicine,” with a particular focus on Preventative Care & Health Equity. In this blog post, we’ll delve into the significance of this panel discussion and introduce you to the distinguished experts who will be leading the conversation.

The Promise of Personalized Medicine

Personalized medicine represents a paradigm shift in healthcare. It leverages our expanding knowledge of the human genome and molecular markers of diseases to not only diagnose and treat but also prevent illnesses. With the help of cutting-edge technologies and vast datasets, healthcare providers can now predict and prevent diseases, track their progression, and develop tailored strategies for each patient.

Preventative Care & Health Equity

The connection between personalized medicine, preventative care, and health equity cannot be overstated. By individualizing healthcare approaches, we can address each patient’s unique genetic predispositions and risk factors, thus enabling more effective prevention strategies. Moreover, personalized medicine has the potential to bridge the gap in health equity by ensuring that all individuals, regardless of their background or socioeconomic status, receive the care they need.

Meet the Expert Panel

The panel discussion at the Wisconsin Biohealth Summit will be a unique opportunity to hear from experts at the forefront of personalized medicine and health equity. Let’s introduce you to the distinguished speakers:

  1. Lisa Cadmus-BertramModerator
    • Associate Professor, Department of Kinesiology, UW-SMPH
    • Background: Lisa holds a joint Ph.D. in Epidemiology and Psychology from Yale University and has 14 years of research experience in energetics and cancer. She is a Cancer Prevention and Control program member at the UW Carbone Cancer Center.
  2. Amy Kind
    • Associate Dean for Social Health Sciences and Programs, UW-SMPH
    • Background: Dr. Amy J.H. Kind, MD, PhD, is a world-renowned expert in disparities-focused exposome science, social determinants, and Alzheimer’s disease. Her groundbreaking research has led to new NIH and Congressional initiatives and provides the foundation for Medicare’s 2023 federal equity-payment models.
  3. Honey Reddi
    • Professor, Department of Pathology and CTSI; Division Director Precision Medicine and Cytogenic for Pathology, Medical College of Wisconsin
    • Background: Dr. Reddi is an ABMGG-certified molecular geneticist with over two decades of translational research experience. She is currently a Professor and Chief for the Division of Clinical Genomics and Director of the Precision Medicine Laboratory at the Medical College of Wisconsin.

The panel discussion is proudly sponsored by the All of Us Research Program, emphasizing the importance of diversity and inclusion in biomedical research and personalized medicine.

The Wisconsin Biohealth Summit’s panel on Preventative Care & Health Equity is a significant event in the journey toward the next generation of personalized medicine. With the expertise of Lisa Cadmus-Bertram, Amy Kind, and Honey Reddi, attendees can expect a deep dive into the intersection of genetics, prevention, and equity in healthcare.

If you’re passionate about the future of medicine, the potential for preventing diseases before they strike, and ensuring equitable access to these groundbreaking advancements, mark your calendars for October 17th. The Overture Performing Arts Center will be the stage for a discussion that promises to inspire, inform, and shape the future of healthcare in Wisconsin and beyond.